Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Oncoimmunology|August 1, 2025
Immune modulation following α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor modelHannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt, et al.Cancers|January 9, 2021
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with PembrolizumabGil Awada, Yanina Jansen, Julia Katharina Schwarze, et al.Oncotarget|July 3, 2018
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approachesMaarten Versteven, Johan M J Van den Bergh, Katrijn Broos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor MicroenvironmentThomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, et al.Theranostics|November 1, 2023
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8<sup>+</sup> T cell and iNKT cell activating mRNA vaccineThomas Ertveldt, Sofie Meulewaeter, Yannick De Vlaeminck, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.Frontiers in Immunology|May 2, 2022
TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 ImmunotherapyKirsten De Ridder, Hanne Locy, Elisa Piccioni, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.Pageof 7